A study to evaluate the efficacy, safety and immunogenicity of SARS-CoV-2 vaccine (Vero Cells), inactivated in healthy adults aged 18 years and older (COVID-19) - full text view - ClinicalTrials.gov
Accessed January 24, 2022 at: